Skip to content
PubMed This is a summary of 146 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 146 referenced papers

Top Authors

Ingrid E. Scheffer
Royal Children's Hospital
Sameer M. Zuberi
Royal Hospital for Children
Rikke S. Møller
University of Southern Denmark
Amy C. Sturm
The Ohio State University Wexner Medical Center
Daniel J. Rader
University of Pennsylvania
Heidi L. Rehm
Broad Institute
Bob C. Mulder
Wageningen University & Research
Jantien van Berkel
Wageningen University & Research
Nienke Lindt
Wageningen University & Research
Sue Richards
Oregon Health & Science University

Top Institutions

Ranked by publications Top 10 institutions

References

References (146)
  1. 1

    Diagnostic Approach to Genetic Causes of Early-Onset Epileptic Encephalopathy.

    Gürsoy S, Erçal D

    Journal of child neurology 2016; (31(4)):523-32 doi:10.1177/0883073815599262.

    PMID: 26271793
  2. 2

    A population-based post mortem study of sudden unexpected death in epilepsy.

    Clark D, Riney K

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2016; (23()):58-62 doi:10.1016/j.jocn.2015.04.027.

    PMID: 26387918
  3. 3

    Dendritic Spine Instability in a Mouse Model of CDKL5 Disorder Is Rescued by Insulin-like Growth Factor 1.

    Della Sala G, Putignano E, Chelini G, et al.

    Biological psychiatry 2016; (80(4)):302-311 doi:10.1016/j.biopsych.2015.08.028.

    PMID: 26452614
  4. 4

    Epileptic spasms: a previously unreported manifestation of WDR45 gene mutation.

    Xixis KI, Mikati MA

    Epileptic disorders : international epilepsy journal with videotape 2015; (17(4)):467-72 doi:10.1684/epd.2015.0784.

    PMID: 26609730
  5. 5

    Dravet Syndrome: Diagnosis and Long-Term Course.

    Connolly MB

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2016; (43 Suppl 3()):S3-8 doi:10.1017/cjn.2016.243.

    PMID: 27264139
  6. 6

    A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.

    Sun Y, Paşca SP, Portmann T, et al.

    eLife 2016; (5()).

    PMID: 27458797
  7. 7

    The Expanding Clinical Spectrum of Genetic Pediatric Epileptic Encephalopathies.

    Shbarou R, Mikati MA

    Seminars in pediatric neurology 2016; (23(2)):134-42.

    PMID: 27544470
  8. 8

    Heterozygous STXBP1 Mutations Associated With Ohtahara Syndrome: Two Littles Make a Lot.

    Nieto-Estévez V, Hsieh J

    Epilepsy currents 2016; (16(5)):330-332 doi:10.5698/1535-7511-16.5.330.

    PMID: 27799865
  9. 9

    Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy.

    Dilena R, Striano P, Gennaro E, et al.

    Brain & development 2017; (39(4)):345-348 doi:10.1016/j.braindev.2016.10.015.

    PMID: 27876397
  10. 10

    Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.

    Alejandra Restrepo-Cordoba M, Campuzano O, Ripoll-Vera T, et al.

    Journal of cardiovascular translational research 2017; (10(1)):35-46 doi:10.1007/s12265-017-9730-8.

    PMID: 28138913
  11. 11

    CDKL5 deficiency entails sleep apneas in mice.

    Lo Martire V, Alvente S, Bastianini S, et al.

    Journal of sleep research 2017; (26(4)):495-497 doi:10.1111/jsr.12512.

    PMID: 28230307
  12. 12

    Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.

    Wolff M, Johannesen KM, Hedrich UBS, et al.

    Brain : a journal of neurology 2017; (140(5)):1316-1336 doi:10.1093/brain/awx054.

    PMID: 28379373
  13. 13

    Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

    Devinsky O, Cross JH, Laux L, et al.

    The New England journal of medicine 2017; (376(21)):2011-2020 doi:10.1056/NEJMoa1611618.

    PMID: 28538134
  14. 14

    Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.

    Lim Z, Wong K, Olson HE, et al.

    Epilepsia 2017; (58(8)):1415-1422 doi:10.1111/epi.13813.

    PMID: 28605011
  15. 15

    Nocturnal seizures are associated with more severe hypoxemia and increased risk of postictal generalized EEG suppression.

    Latreille V, Abdennadher M, Dworetzky BA, et al.

    Epilepsia 2017; (58(9)):e127-e131 doi:10.1111/epi.13841.

    PMID: 28714130
  16. 16

    Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.

    Sha YK, Sha YW, Mei LB, et al.

    Gene 2017; (634()):1-4 doi:10.1016/j.gene.2017.08.040.

    PMID: 28870863
  17. 17

    Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

    Sturm AC, Knowles JW, Gidding SS, et al.

    Journal of the American College of Cardiology 2018; (72(6)):662-680 doi:10.1016/j.jacc.2018.05.044.

    PMID: 30071997
  18. 18

    Neonatal tremor episodes and hyperekplexia-like presentation at onset in a child with SCN8A developmental and epileptic encephalopathy.

    Pons L, Lesca G, Sanlaville D, et al.

    Epileptic disorders : international epilepsy journal with videotape 2018; (20(4)):289-294 doi:10.1684/epd.2018.0988.

    PMID: 30078772
  19. 19

    Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review.

    Kuersten M, Tacke M, Gerstl L, et al.

    European journal of medical genetics 2020; (63(1)):103628 doi:10.1016/j.ejmg.2019.02.001.

    PMID: 30771507
  20. 20

    Haematologists and palliative care: a multicentric qualitative study.

    Tricou C, Munier S, Phan-Hoang N, et al.

    BMJ supportive & palliative care 2022; (12(e6)):e798-e802 doi:10.1136/bmjspcare-2018-001714.

    PMID: 30808629
  21. 21

    Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures.

    Denis J, Villeneuve N, Cacciagli P, et al.

    Epilepsia 2019; (60(5)):845-856 doi:10.1111/epi.14727.

    PMID: 31026061
  22. 22

    Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases.

    Leone A, De Amicis R, Lessa C, et al.

    Nutrients 2019; (11(5)) doi:10.3390/nu11051104.

    PMID: 31108981
  23. 23

    Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.

    Buck ML, Goodkin HP

    The Annals of pharmacotherapy 2019; (53(11)):1136-1144 doi:10.1177/1060028019856008.

    PMID: 31167540
  24. 24

    Association of quality of paediatric epilepsy care with mortality and unplanned hospital admissions among children and young people with epilepsy in England: a national longitudinal data linkage study.

    Hargreaves DS, Arora S, Viveiro C, et al.

    The Lancet. Child & adolescent health 2019; (3(9)):627-635 doi:10.1016/S2352-4642(19)30201-9.

    PMID: 31281027
  25. 25

    CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.

    Demarest ST, Olson HE, Moss A, et al.

    Epilepsia 2019; (60(8)):1733-1742 doi:10.1111/epi.16285.

    PMID: 31313283
  26. 26

    Dravet Syndrome: An Overview.

    Anwar A, Saleem S, Patel UK, et al.

    Cureus 2019; (11(6)):e5006 doi:10.7759/cureus.5006.

    PMID: 31497436
  27. 27

    A de novo KCNQ2 Gene Mutation Associated With Non-familial Early Onset Seizures: Case Report and Revision of Literature Data.

    Laccetta G, Fiori S, Giampietri M, et al.

    Frontiers in pediatrics 2019; (7()):348 doi:10.3389/fped.2019.00348.

    PMID: 31552204
  28. 28

    Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic.

    Kadam SD, Sullivan BJ, Goyal A, et al.

    International journal of molecular sciences 2019; (20(20)) doi:10.3390/ijms20205098.

    PMID: 31618813
  29. 29

    Genetic and clinical features of SCN8A developmental and epileptic encephalopathy.

    Kim HJ, Yang D, Kim SH, et al.

    Epilepsy research 2019; (158()):106222 doi:10.1016/j.eplepsyres.2019.106222.

    PMID: 31675620
  30. 30

    Recommendations for the management of renal involvement in the tuberous sclerosis complex.

    Ariceta G, Buj MJ, Furlano M, et al.

    Nefrologia 2020; (40(2)):142-151 doi:10.1016/j.nefro.2019.07.002.

    PMID: 31722796
  31. 31

    SCN2A channelopathies: Mechanisms and models.

    Hedrich UBS, Lauxmann S, Lerche H

    Epilepsia 2019; (60 Suppl 3()):S68-S76 doi:10.1111/epi.14731.

    PMID: 31904120
  32. 32

    SCN1A/NaV 1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models.

    Mantegazza M, Broccoli V

    Epilepsia 2019; (60 Suppl 3()):S25-S38 doi:10.1111/epi.14700.

    PMID: 31904127
  33. 33

    CDKL5 Deficiency Disorder-A Complex Epileptic Encephalopathy.

    Jakimiec M, Paprocka J, Śmigiel R

    Brain sciences 2020; (10(2)) doi:10.3390/brainsci10020107.

    PMID: 32079229
  34. 34

    Ataxia, tremor, intellectual disability: a case of STXBP1 encephalopathy with a new mutation.

    Değerliyurt A, Kesen GG, Ceylaner S

    The Turkish journal of pediatrics 2019; (61(5)):757-759.

    PMID: 32105008
  35. 35

    Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.

    Na JH, Shin S, Yang D, et al.

    Brain & development 2020; (42(6)):438-448 doi:10.1016/j.braindev.2020.02.004.

    PMID: 32139178
  36. 36

    Cardiac arrhythmias in Dravet syndrome: an observational multicenter study.

    Shmuely S, Surges R, Helling RM, et al.

    Annals of clinical and translational neurology 2020; (7(4)):462-473 doi:10.1002/acn3.51017.

    PMID: 32207228
  37. 37

    A novel nonsense variant in SLC24A4 causing a rare form of amelogenesis imperfecta in a Pakistani family.

    Khan SA, Khan MA, Muhammad N, et al.

    BMC medical genetics 2020; (21(1)):97 doi:10.1186/s12881-020-01038-6.

    PMID: 32380970
  38. 38

    Use of Remote Monitoring by E-mail for Long-Term Management of the Classic Ketogenic Diet.

    Ferraris C, Guglielmetti M, Tamagni E, et al.

    Nutrients 2020; (12(6)) doi:10.3390/nu12061833.

    PMID: 32575586
  39. 39

    Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence.

    Melikishvili G, Dulac O, Gataullina S

    Epilepsy & behavior : E&B 2020; (111()):107187 doi:10.1016/j.yebeh.2020.107187.

    PMID: 32603808
  40. 40

    Association between palliative care and healthcare outcomes among adults with terminal non-cancer illness: population based matched cohort study.

    Quinn KL, Stukel T, Stall NM, et al.

    BMJ (Clinical research ed.) 2020; (370()):m2257 doi:10.1136/bmj.m2257.

    PMID: 32631907
  41. 41

    Wearable seizure detection devices in refractory epilepsy.

    Verdru J, Van Paesschen W

    Acta neurologica Belgica 2020; (120(6)):1271-1281 doi:10.1007/s13760-020-01417-z.

    PMID: 32632710
  42. 42

    Biallelic SZT2 variants in a child with developmental and epileptic encephalopathy.

    Tanaka R, Takahashi S, Kuroda M, et al.

    Epileptic disorders : international epilepsy journal with videotape 2020; (22(4)):501-505 doi:10.1684/epd.2020.1187.

    PMID: 32723703
  43. 43

    Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late.

    Minardi R, Licchetta L, Baroni MC, et al.

    Clinical genetics 2020; (98(5)):477-485 doi:10.1111/cge.13823.

    PMID: 32725632
  44. 44

    Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.

    Rymen D, Lindhout M, Spanou M, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2020; (22(10)):1589-1597 doi:10.1038/s41436-020-0933-z.

    PMID: 32820246
  45. 45

    Determinants of overburdening among informal carers: a systematic review.

    Lindt N, van Berkel J, Mulder BC

    BMC geriatrics 2020; (20(1)):304 doi:10.1186/s12877-020-01708-3.

    PMID: 32847493
  46. 46

    Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome.

    Han Z, Chen C, Christiansen A, et al.

    Science translational medicine 2020; (12(558)) doi:10.1126/scitranslmed.aaz6100.

    PMID: 32848094
  47. 47

    Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review.

    Menezes LFS, Sabiá Júnior EF, Tibery DV, et al.

    Frontiers in pharmacology 2020; (11()):1276 doi:10.3389/fphar.2020.01276.

    PMID: 33013363
  48. 48

    Clinical spectrum and treatment outcome of 95 children with continuous spikes and waves during sleep (CSWS).

    Sonnek B, Döring JH, Mütze U, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2021; (30()):121-127 doi:10.1016/j.ejpn.2020.10.010.

    PMID: 33132036
  49. 49

    Developmental and epileptic encephalopathies: what we do and do not know.

    Specchio N, Curatolo P

    Brain : a journal of neurology 2021; (144(1)):32-43 doi:10.1093/brain/awaa371.

    PMID: 33279965
  50. 50

    Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy.

    Wang W, Frankel WN

    Neurobiology of disease 2021; (148()):105220 doi:10.1016/j.nbd.2020.105220.

    PMID: 33301879
  51. 51

    Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta-analysis.

    Zhang L, Li W, Wang C

    Acta neurologica Scandinavica 2021; (143(4)):339-348 doi:10.1111/ane.13387.

    PMID: 33336426
  52. 52

    The phenotype caused by recessive variations in SLC25A22: Report of a new case and literature review.

    André MV, Cacciagli P, Cano A, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2021; (28(1)):87-92 doi:10.1016/j.arcped.2020.10.015.

    PMID: 33342683
  53. 53

    Inappropriate end-of-life cancer care in a generalist and specialist palliative care model: a nationwide retrospective population-based observational study.

    Boddaert MS, Pereira C, Adema J, et al.

    BMJ supportive & palliative care 2022; (12(e1)):e137-e145 doi:10.1136/bmjspcare-2020-002302.

    PMID: 33355176
  54. 54

    The probability of sudden unexpected death in epilepsy given postictal prone position.

    Esmaeili B, Dworetzky BA, Glynn RJ, Lee JW

    Epilepsy & behavior : E&B 2021; (116()):107775 doi:10.1016/j.yebeh.2021.107775.

    PMID: 33571837
  55. 55

    Postictal Death Is Associated with Tonic Phase Apnea in a Mouse Model of Sudden Unexpected Death in Epilepsy.

    Wenker IC, Teran FA, Wengert ER, et al.

    Annals of neurology 2021; (89(5)):1023-1035 doi:10.1002/ana.26053.

    PMID: 33604927
  56. 56

    Autonomic Characteristics of Sudden Unexpected Death in Epilepsy in Children-A Systematic Review of Studies and Their Relevance to the Management of Epilepsy in Rett Syndrome.

    Singh J, Lanzarini E, Santosh P

    Frontiers in neurology 2020; (11()):632510 doi:10.3389/fneur.2020.632510.

    PMID: 33613425
  57. 57

    Developmental and epileptic encephalopathies: recognition and approaches to care.

    Raga S, Specchio N, Rheims S, Wilmshurst JM

    Epileptic disorders : international epilepsy journal with videotape 2021; (23(1)):40-52 doi:10.1684/epd.2021.1244.

    PMID: 33632673
  58. 58

    SCN8A-related developmental and epileptic encephalopathy with ictal asystole requiring cardiac pacemaker implantation.

    Negishi Y, Aoki Y, Itomi K, et al.

    Brain & development 2021; (43(7)):804-808 doi:10.1016/j.braindev.2021.03.004.

    PMID: 33827760
  59. 59

    SCN8A Encephalopathy: Case Report and Literature Review.

    Fan HC, Lee HF, Chi CS

    Neurology international 2021; (13(2)):143-150 doi:10.3390/neurolint13020014.

    PMID: 33915942
  60. 60

    Migrating Focal Seizures and Myoclonic Status in ARV1-Related Encephalopathy.

    Darra F, Lo Barco T, Opri R, et al.

    Neurology. Genetics 2021; (7(3)):e593 doi:10.1212/NXG.0000000000000593.

    PMID: 34017911
  61. 61

    Gastrointestinal Symptoms and Channelopathy-Associated Epilepsy.

    Beck VC, Isom LL, Berg AT

    The Journal of pediatrics 2021; (237()):41-49.e1 doi:10.1016/j.jpeds.2021.06.034.

    PMID: 34181986
  62. 62

    Renal agenesis-related genes are associated with Herlyn-Werner-Wunderlich syndrome.

    Li L, Chu C, Li S, et al.

    Fertility and sterility 2021; (116(5)):1360-1369 doi:10.1016/j.fertnstert.2021.06.033.

    PMID: 34311961
  63. 63

    Tremor-like subcortical myoclonus in STXBP1 encephalopathy.

    Loussouarn A, Doummar D, Beaugendre Y, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2021; (34()):62-66 doi:10.1016/j.ejpn.2021.06.005.

    PMID: 34392114
  64. 64

    The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway.

    Leren TP, Bogsrud MP

    Journal of clinical lipidology 2021; (15(5)):674-681 doi:10.1016/j.jacl.2021.08.007.

    PMID: 34479846
  65. 65

    Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.

    Brock D, Fidell A, Thomas J, et al.

    Journal of child neurology 2021; (36(11)):974-980 doi:10.1177/08830738211019284.

    PMID: 34547934
  66. 66

    Autonomic manifestations of epilepsy: emerging pathways to sudden death?

    Thijs RD, Ryvlin P, Surges R

    Nature reviews. Neurology 2021; (17(12)):774-788 doi:10.1038/s41582-021-00574-w.

    PMID: 34716432
  67. 67

    Genetic evaluation of children with autism spectrum disorders in developing and low-resource areas.

    Masri AT, Nasir A, Irshaid F, et al.

    Autism : the international journal of research and practice 2022; (26(6)):1491-1498 doi:10.1177/13623613211055535.

    PMID: 34781785
  68. 68

    Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model.

    Li M, Jancovski N, Jafar-Nejad P, et al.

    The Journal of clinical investigation 2021; (131(23)).

    PMID: 34850743
  69. 69

    Genotype-phenotype correlations in SCN8A-related epilepsy: a cohort study of Chinese children in southern China.

    Peng BW, Tian Y, Chen L, et al.

    Brain : a journal of neurology 2022; (145(4)):e24-e27 doi:10.1093/brain/awac038.

    PMID: 35230384
  70. 70

    A Treatable Genetic Disease Caused by CAD Mutation.

    Peng X, Xia LP, Zhang HJ, et al.

    Frontiers in pediatrics 2022; (10()):771374 doi:10.3389/fped.2022.771374.

    PMID: 35356445
  71. 71

    Genetic analysis using targeted exome sequencing of 53 Vietnamese children with developmental and epileptic encephalopathies.

    Hieu NLT, Thu NTM, Ngan LTA, et al.

    American journal of medical genetics. Part A 2022; (188(7)):2048-2060 doi:10.1002/ajmg.a.62741.

    PMID: 35365919
  72. 72

    Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long-read sequencing.

    Mehinovic E, Gray T, Campbell M, et al.

    American journal of medical genetics. Part A 2022; (188(7)):2071-2081 doi:10.1002/ajmg.a.62743.

    PMID: 35366058
  73. 73

    Long-term outcome of developmental and epileptic encephalopathies.

    Van Bogaert P

    Revue neurologique 2022; (178(7)):659-665 doi:10.1016/j.neurol.2022.01.009.

    PMID: 35489823
  74. 74

    Ganaxolone: First Approval.

    Lamb YN

    Drugs 2022; (82(8)):933-940 doi:10.1007/s40265-022-01724-0.

    PMID: 35596878
  75. 75

    Rare variant of TBL1XR1 in West syndrome: A case report.

    Shen Y, Yuan M, Luo H, et al.

    Molecular genetics & genomic medicine 2022; (10(7)):e1991 doi:10.1002/mgg3.1991.

    PMID: 35611576
  76. 76

    Early infantile epileptic encephalopathy related to NECAP1: Clinical delineation of the disease and review.

    Chouery E, Mehawej C, Sabbagh S, et al.

    European journal of neurology 2022; (29(8)):2486-2492 doi:10.1111/ene.15424.

    PMID: 35638367
  77. 77

    Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice.

    Scheffer IE, Bennett CA, Gill D, et al.

    Developmental medicine and child neurology 2023; (65(1)):50-57 doi:10.1111/dmcn.15308.

    PMID: 35701389
  78. 78

    Developmental and Epileptic Encephalopathies in Adults: An Evolving Field.

    Gorodetsky C, Fasano A

    Neurology 2022; (99(3)):89-91 doi:10.1212/WNL.0000000000200190.

    PMID: 35851555
  79. 79

    Updates on the diagnostic evaluation, genotype-phenotype correlation, and treatments of genetic epilepsies.

    Zimmern V, Korff C

    Current opinion in pediatrics 2022; (34(6)):538-543 doi:10.1097/MOP.0000000000001170.

    PMID: 36081356
  80. 80

    Ketogenic diet therapy in children with epilepsy caused by SLC2A1 mutations: a single-center single-arm retrospective study.

    Wang YY, Zhou YQ, Luo LJ, et al.

    World journal of pediatrics : WJP 2024; (20(5)):517-524 doi:10.1007/s12519-022-00620-7.

    PMID: 36303089
  81. 81

    Novel homozygous AP3B2 mutations in four individuals with developmental and epileptic encephalopathy: A rare clinical entity.

    Dilber C, Yücel G, Şahin Y

    Clinical neurology and neurosurgery 2022; (223()):107509 doi:10.1016/j.clineuro.2022.107509.

    PMID: 36356440
  82. 82

    Solute carrier transporter disease and developmental and epileptic encephalopathy.

    Gan Y, Wei Z, Liu C, et al.

    Frontiers in neurology 2022; (13()):1013903 doi:10.3389/fneur.2022.1013903.

    PMID: 36419532
  83. 83

    An Atypical, Staged Cell Death Pathway Induced by Depletion of SNARE-Proteins MUNC18-1 or Syntaxin-1.

    Feringa FM, van Berkel AA, Nair A, Verhage M

    The Journal of neuroscience : the official journal of the Society for Neuroscience 2023; (43(3)):347-358 doi:10.1523/JNEUROSCI.0611-22.2022.

    PMID: 36517239
  84. 84

    The uncertainty of copy number variants: pregnancy decisions and clinical follow-up.

    Shi P, Liang H, Hou Y, et al.

    American journal of obstetrics and gynecology 2023; (229(2)):170.e1-170.e8 doi:10.1016/j.ajog.2023.01.022.

    PMID: 36716986
  85. 85

    CDKL5-associated developmental and epileptic encephalopathy: A long-term, longitudinal electroclinical study of 22 cases.

    Darra F, Monchelato M, Loos M, et al.

    Epilepsy research 2023; (190()):107098 doi:10.1016/j.eplepsyres.2023.107098.

    PMID: 36739728
  86. 86

    Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder.

    De SK

    Current medicinal chemistry 2024; (31(4)):388-392 doi:10.2174/0929867330666230320123952.

    PMID: 36959132
  87. 87

    Waiting to Inhale: Preventing Fatality From Seizure-Induced Apnea.

    Wenker IC, Patel MK

    Epilepsy currents 2023; (23(3)):185-187 doi:10.1177/15357597231159466.

    PMID: 37334424
  88. 88

    Natural History and Developmental Trajectories of Individuals With Disease-Causing Variants in STXBP1.

    Thalwitzer KM, Driedger JH, Xian J, et al.

    Neurology 2023; (101(9)):e879-e891 doi:10.1212/WNL.0000000000207550.

    PMID: 37407264
  89. 89

    First report of Tunisian patients with CDKL5-related encephalopathy.

    Charfi Triki C, Zouari Mallouli S, Ben Jdila M, et al.

    Epilepsia open 2024; (9(3)):906-917 doi:10.1002/epi4.12824.

    PMID: 37701975
  90. 90

    Antisense oligonucleotides restore excitability, GABA signalling and sodium current density in a Dravet syndrome model.

    Yuan Y, Lopez-Santiago L, Denomme N, et al.

    Brain : a journal of neurology 2024; (147(4)):1231-1246 doi:10.1093/brain/awad349.

    PMID: 37812817
  91. 91

    Sudden unexpected death in epilepsy disclosure causes anxiety in patients with epilepsy: a Chinese questionnaire survey.

    Pan Y, Hu G, Wang Z, et al.

    Frontiers in neurology 2023; (14()):1284050 doi:10.3389/fneur.2023.1284050.

    PMID: 38033778
  92. 92

    Early onset developmental and epileptic encephalopathy and Rett-like phenotype in a 15-year-old girl affected by Cornelia de Lange syndrome type 2 due to a SMC1A gene mutation.

    Parmeggiani L, Stanzial F, Menna E, et al.

    Epilepsy & behavior reports 2023; (24()):100634 doi:10.1016/j.ebr.2023.100634.

    PMID: 38076278
  93. 93

    Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep.

    Licchetta L, Di Giorgi L, Santucci M, et al.

    Molecular genetics & genomic medicine 2024; (12(1)):e2311 doi:10.1002/mgg3.2311.

    PMID: 38087948
  94. 94

    Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.

    Bayat A, Iavarone S, Miceli F, et al.

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2024; (21(1)):e00296 doi:10.1016/j.neurot.2023.10.006.

    PMID: 38241158
  95. 95

    Transitional Care Navigation.

    Rodriguez AL, Cappelletti L, Kurian SM, et al.

    Seminars in oncology nursing 2024; (40(2)):151580 doi:10.1016/j.soncn.2024.151580.

    PMID: 38290928
  96. 96

    PGAP2-Related Hyperphosphatasia-Mental Retardation Syndrome: Report of a Novel Patient, Toward a Broadening of Phenotypic Spectrum and Therapeutic Perspectives.

    Saracino A, Totaro M, Politano D, et al.

    Neuropediatrics 2024; (55(2)):129-134 doi:10.1055/s-0044-1779613.

    PMID: 38365198
  97. 97

    Reduced Protein Stability of 11 Pathogenic Missense STXBP1/MUNC18-1 Variants and Improved Disease Prediction.

    André T, van Berkel AA, Singh G, et al.

    Biological psychiatry 2024; (96(2)):125-136 doi:10.1016/j.biopsych.2024.03.007.

    PMID: 38490366
  98. 98

    Enhancing the action of serotonin by three different mechanisms prevents spontaneous seizure-induced mortality in Dravet mice.

    Guo J, Min D, Farrell EK, et al.

    Epilepsia 2024; (65(6)):1791-1800 doi:10.1111/epi.17966.

    PMID: 38593237
  99. 99

    Predictors of genetic diagnosis in individuals with developmental and epileptic encephalopathies.

    Luiza Benevides M, de Moraes HT, Granados DMM, et al.

    Epilepsy & behavior : E&B 2024; (155()):109762 doi:10.1016/j.yebeh.2024.109762.

    PMID: 38636144
  100. 100

    Clinical analysis of developmental and/or epileptic encephalopathy with spike-and-wave activation in sleep: A single tertiary care center experience in China.

    Zhang Y, Li C, Zhou Y, et al.

    Seizure 2024; (119()):52-57 doi:10.1016/j.seizure.2024.05.012.

    PMID: 38796951
  101. 101

    Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox-Gastaut syndrome in clinical practice.

    Wirrell EC, Lagae L, Scheffer IE, et al.

    Epilepsia open 2024; (9(5)):1643-1657 doi:10.1002/epi4.12998.

    PMID: 38962968
  102. 102

    Dentate gyrus granule cells are a locus of pathology in Scn8a developmental encephalopathy.

    Yu W, Hill SF, Zhu L, et al.

    Neurobiology of disease 2024; (199()):106591 doi:10.1016/j.nbd.2024.106591.

    PMID: 38969233
  103. 103

    Potentially Inappropriate End of Life Care and Healthcare Costs in the Last 30 Days of Life in Regions Providing Integrated Palliative Care in the Netherlands: A Registration-based Study.

    Pereira CFR, Dijxhoorn AQ, Koekoek B, et al.

    International journal of integrated care 2024; (24(3)):6 doi:10.5334/ijic.7504.

    PMID: 39005964
  104. 104

    Timely integration of palliative care. the reality check. a retrospective analysis.

    Adamidis F, Baumgartner NS, Kitta A, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2024; (32(8)):518 doi:10.1007/s00520-024-08721-x.

    PMID: 39017732
  105. 105

    Developmental epileptic encephalopathy caused by homozygosity of a c.172+1G>C variant in the WWOX gene.

    You Y, Wu W, Du Y, et al.

    Molecular genetics & genomic medicine 2024; (12(8)):e2500 doi:10.1002/mgg3.2500.

    PMID: 39101447
  106. 106

    Patients' and Providers' Perspectives of the Transition of Care from Hospital to Community for Hispanic/Latino Adults with Diabetes.

    Padilla BI, Granados E, Corsino L

    Hispanic health care international : the official journal of the National Association of Hispanic Nurses 2025; (23(2)):85-93 doi:10.1177/15404153241269473.

    PMID: 39105422
  107. 107

    How Encephalopathy Impacts Language Ability: A Scoping Review of the Linguistic Abilities of Adults with Developmental and Epileptic Encephalopathy.

    Papatheodorou I, Stavrakaki S, Koukoulioti V, et al.

    Medicina (Kaunas, Lithuania) 2024; (60(10)) doi:10.3390/medicina60101635.

    PMID: 39459422
  108. 108

    Case report: Adult patient with WWOX developmental and epileptic encephalopathy: 40 years of observation.

    Teplyshova A, Sharkov A

    Frontiers in genetics 2024; (15()):1477466 doi:10.3389/fgene.2024.1477466.

    PMID: 39507621
  109. 109

    Pharmacotherapeutic strategies for drug-resistant epilepsy in children.

    Auvin S, Specchio N

    Epilepsy & behavior : E&B 2024; (161()):110139 doi:10.1016/j.yebeh.2024.110139.

    PMID: 39515006
  110. 110

    Diagnostic value of EEG after a first unprovoked seizure in adults - A population-based study.

    Joelsson S, Andersson K, Brannefors P, et al.

    Epilepsy & behavior : E&B 2025; (162()):110151 doi:10.1016/j.yebeh.2024.110151.

    PMID: 39615259
  111. 111

    Anatomo-Electro-Clinical Phenotypes in Children With Epilepsy and DYNC1H1 Mutations.

    Gutiérrez-Delicado E, García-Fernández M, Ortiz Cabrera NV, et al.

    Pediatric neurology 2025; (163()):7-11 doi:10.1016/j.pediatrneurol.2024.11.003.

    PMID: 39631264
  112. 112

    Health system related kidney supportive care interventions for adults with chronic kidney disease: A systematic review.

    Dharmagunawardene D, Kularatna S, Halahakone U, et al.

    Journal of renal care 2025; (51(1)):e12517 doi:10.1111/jorc.12517.

    PMID: 39639604
  113. 113

    Facilitators, barriers, and guidance to successful implementation of multidisciplinary transitional care interventions: A qualitative systematic review using the consolidated framework for implementation research.

    Collet R, van Grootel J, van der Leeden M, et al.

    International journal of nursing studies advances 2025; (8()):100269 doi:10.1016/j.ijnsa.2024.100269.

    PMID: 39691681
  114. 114

    Deregulated ion channels contribute to RHOBTB2-associated developmental and epileptic encephalopathy.

    Langhammer F, Gregor A, Ntamati NR, et al.

    Human molecular genetics 2025; (34(7)):639-650 doi:10.1093/hmg/ddae183.

    PMID: 39849855
  115. 115

    Fulfilling the needs of caregivers in delivering health services to children with developmental and epileptic encephalopathies.

    Kelada L, Best S, Pierce K, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (54()):147-158 doi:10.1016/j.ejpn.2025.01.007.

    PMID: 39919518
  116. 116

    Multiplexed Assays of Variant Effect and Reclassification of TYR Variants in Chinese Patients with Oculocutaneous Albinism.

    Lv S, Hao Z, Li W, Wei A

    The Journal of investigative dermatology 2025; (145(11)):2798-2810.e5 doi:10.1016/j.jid.2025.03.038.

    PMID: 40252993
  117. 117

    Healthcare transition and inflammatory bowel disease: the challenges experienced by young adults after transfer from paediatric to adult health services.

    Constantinidis DD, O'Brien CL, Hebbard G, et al.

    Psychology, health & medicine 2025; 1-23 doi:10.1080/13548506.2025.2497001.

    PMID: 40301717
  118. 118

    The association between stroke and caregiver employment after survivors' discharge: a cross-sectional analysis within a longitudinal study.

    Petrosino F, Bartoli D, Iovino P, et al.

    European journal of cardiovascular nursing 2025; (24(7)):1067-1074 doi:10.1093/eurjcn/zvaf080.

    PMID: 40304449
  119. 119

    Comprehensive genetic diagnosis and therapeutic perspectives in 155 children with developmental and epileptic encephalopathy.

    van Heurck R, Hammar EB, Ville D, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (56()):97-103 doi:10.1016/j.ejpn.2025.04.014.

    PMID: 40347601
  120. 120

    Developmental and epileptic encephalopathy with spike-wave activation in sleep: From the 'functional ablation' model to a neurodevelopmental network perspective.

    Andreoli L, Bova SM, Veggiotti P

    Developmental medicine and child neurology 2025; (67(10)):1250-1256 doi:10.1111/dmcn.16361.

    PMID: 40356337
  121. 121

    Caregiver-reported meaningful change in functional domains for individuals with developmental and epileptic encephalopathy: A convergent mixed-methods design.

    Downs J, Haywood S, Ludwig NN, et al.

    Developmental medicine and child neurology 2025; (67(12)):1616-1627 doi:10.1111/dmcn.16363.

    PMID: 40372822
  122. 122

    Intersection of epilepsy and cardiac health: Insights from electrocardiography and syndromic associations.

    Akyuz E, Aslan FS, Eyigurbuz T

    Epilepsia 2025; (66(10)):3656-3675 doi:10.1111/epi.18502.

    PMID: 40512607
  123. 123

    Study of caregiver stress among carers of patients of cognitive impairment: An observational study from memory clinic of AIIMS, India.

    Kumari B, Chakrawarty A, Rao AR, et al.

    Journal of family medicine and primary care 2025; (14(5)):1728-1734 doi:10.4103/jfmpc.jfmpc_1069_24.

    PMID: 40547749
  124. 124

    The Impact of Perceived Self-Efficacy on Healthcare Transition Outcomes: Perceptions From Parents and Young People.

    Kwok C, Waller D, Kohn M, Doyle FL

    Child: care, health and development 2025; (51(4)):e70125 doi:10.1111/cch.70125.

    PMID: 40562061
  125. 125

    Transitioning spine care from the pediatric to adult center: Challenges and future directions.

    Shen J, Klineberg E, Yaszay B, et al.

    Health care transitions 2025; (3()):100107 doi:10.1016/j.hctj.2025.100107.

    PMID: 40599635
  126. 126

    Developmental and Epileptic Encephalopathy as a Novel Clinical Hallmark of SCA21.

    Mastrangelo M, Ricciardi G, Greco C, et al.

    Neuropediatrics 2025; (56(6)):404-407 doi:10.1055/a-2646-2535.

    PMID: 40602760
  127. 127

    Cardiac arrhythmias in sudden unexpected death in epilepsy: A systematic review.

    Ermongkonchai T, Kwok M, Prinsloo D, et al.

    Epilepsy & behavior : E&B 2025; (171()):110582 doi:10.1016/j.yebeh.2025.110582.

    PMID: 40618461
  128. 128

    Phenylbutyrate for monogenetic epilepsy: Literature review.

    Stone A, Burré J, Wayland N, Grinspan ZM

    Epilepsy research 2025; (217()):107621 doi:10.1016/j.eplepsyres.2025.107621.

    PMID: 40633241
  129. 129

    A novel mutation in the DYNC1H1 gene causing developmental and epileptic encephalopathy treated with ketogenic diet: A case report.

    Zhao F, Sun L, Hu W, Zhang H

    Medicine 2025; (104(28)):e43277 doi:10.1097/MD.0000000000043277.

    PMID: 40660528
  130. 130

    Cortical Visual Impairment Across a Range of Neurodevelopmental Disorders: Clinical Characterization, Diagnostic Tool Evaluation, and Association with Developmental Outcomes.

    Abbott M, Angione K, Stringfellow M, et al.

    Journal of child neurology 2026; (41(4)):470-477 doi:10.1177/08830738251361698.

    PMID: 40767165
  131. 131

    Seminar in Epileptology: Normal awake and sleep patterns, interictal abnormalities, and ictal patterns on scalp EEG.

    Alcala-Zermeno JL, Katyal R, Frauscher B, et al.

    Epileptic disorders : international epilepsy journal with videotape 2025; (27(5)):803-866 doi:10.1002/epd2.70071.

    PMID: 40782030
  132. 132

    Abnormalities in the functional activity of neural networks in a human iPSC model of Dravet syndrome.

    Mzezewa R, Hyvärinen T, Kulta O, et al.

    Neuroscience research 2025; (220()):104958 doi:10.1016/j.neures.2025.104958.

    PMID: 40976436
  133. 133

    Nonseizure symptoms and broader seizure impacts in patients with Dravet syndrome and Lennox-Gastaut syndrome in clinical practice settings: Results from a multinational survey.

    Shah D, Villanueva V, Dlugos D, et al.

    Epilepsia open 2025; (10(6)):1783-1797 doi:10.1002/epi4.70118.

    PMID: 40982357
  134. 134

    Quantification of neuromotor control in STXBP1 -Related Disorders with wearable sensors.

    Orlando JM, Bane B, Chisari T, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.09.20.25336193.

    PMID: 41040694
  135. 135

    Add-on ketogenic diet versus antiseizure medications alone in children with developmental and epileptic encephalopathies: a prospective comparative cohort study.

    Hu W, Li L, Zhao F, et al.

    Frontiers in neurology 2025; (16()):1677046 doi:10.3389/fneur.2025.1677046.

    PMID: 41127284
  136. 136

    Dravet syndrome diagnosed in adults.

    Dudley AM, Peña-Ceballos J, El-Naggar H, et al.

    Practical neurology 2026; (26(2)):124-132 doi:10.1136/pn-2025-004743.

    PMID: 41136202
  137. 137

    Genetic Etiology of Developmental and Epileptic Encephalopathy in a Turkish Cohort: A Single-Center Study with Targeted Gene Panel and Whole Exome Sequencing.

    Sunnetci-Akkoyunlu D, Kara B, Ozer T, et al.

    Genes 2025; (16(10)) doi:10.3390/genes16101152.

    PMID: 41153369
  138. 138

    Adult-Onset Neurological Deterioration in Dravet Syndrome Associated With a Novel SCN1A Missense Variant (p.Gly1371Asp): A Case Report.

    Yokoyama K, Miyazaki S, Murayama K, et al.

    Cureus 2025; (17(9)):e93228 doi:10.7759/cureus.93228.

    PMID: 41158906
  139. 139

    Systematic review of indirect costs to families of children with developmental epileptic encephalopathies.

    Abdelmageed S, Du RY, Carroll M, et al.

    Orphanet journal of rare diseases 2025; (20(1)):579 doi:10.1186/s13023-025-04081-9.

    PMID: 41225515
  140. 140

    A multidisciplinary quality improvement initiative to improve neonatal end-of-life care in a level IV NICU.

    Lofgren H, Lentin S, DiMatteo A, et al.

    BMC palliative care 2025; (24(1)):286 doi:10.1186/s12904-025-01899-9.

    PMID: 41225558
  141. 141

    Organizational and behavioral models in the management of patients with developmental and epileptic encephalopathy, Lennox-Gastaut syndrome and Dravet syndrome in Italy: a focus on the transition from pediatric to adult care.

    Di Bonaventura C, Coppola A, Di Gennaro G, et al.

    Frontiers in health services 2025; (5()):1632564 doi:10.3389/frhs.2025.1632564.

    PMID: 41282975
  142. 142

    Clinical and genotypic characteristics of 19 children with STXBP1-encephalopathy.

    Qi L, Fang C, Hu Z

    Medicine 2026; (105(3)):e47269 doi:10.1097/MD.0000000000047269.

    PMID: 41560101
  143. 143

    GLUT1 deficiency syndrome in adulthood: lost in diagnosis.

    Previtali R, Adami L, Benvenuto C, et al.

    BMJ neurology open 2026; (8(1)):e001337 doi:10.1136/bmjno-2025-001337.

    PMID: 41561681
  144. 144

    Real-World Practices in Educating Patients and Caregivers About Sudden Unexpected Death in Epilepsy: A Scoping Review.

    Alzahrani LA, Aldweesh AF, Alotaibi AN, et al.

    Saudi journal of medicine & medical sciences 2026; (14(1)):4-13 doi:10.4103/sjmms.sjmms_114_25.

    PMID: 41675952
  145. 145

    CDKL5 modulates the plasticity of excitatory synapses via liquid-liquid phase separation.

    Li M, Zhu Z, Li D, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2026; (123(8)):e2511123123 doi:10.1073/pnas.2511123123.

    PMID: 41706882
  146. 146

    Timing and outcomes of outpatient palliative care consultations in advanced cancer.

    Torres-Tenor JL, Bruera E, Ortí-Hortelano MJ, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; doi:10.1007/s12094-026-04276-x.

    PMID: 41758445